Medication class
Urinary
Medications for overactive bladder, benign prostatic hyperplasia (BPH), urinary tract infections, and kidney stones.
Data updated 2026-05-15
- 18
- Medications
- 16
- With a generic
- 99%
- Avg generic savings
- 0
- In active shortage
Drug class assignments follow the FDA openFDA therapeutic classification, and clinical details are drawn from FDA Structured Product Labeling (DailyMed). See the full sources below.
PlainMeds tracks 18 urinary medications compiled from official FDA drug labels, including tadalafil, finasteride, sildenafil.
Urinary medications are grouped here by the openFDA therapeutic classification and drawn from FDA Structured Product Labeling. PlainMeds lists 18 in this class, 16 with a lower-cost generic available (averaging about 99% versus brand). Each drug page covers labeled uses, FAERS-reported side effects, interactions, recalls and NADAC pricing. This is educational information from public data, not medical advice.
What urinary drugs cost
Highest NADAC acquisition cost per unit in this class, brand and generic
- sildenafil
sildenafil
$84 per unit
- tadalafil
tadalafil
$54 per unit
- dutasteride/tamsulosin $22
dutasteride/tamsulosin
$22 per unit
- dutasteride $22
dutasteride
$22 per unit
- solifenacin $12
solifenacin
$12 per unit
- mirabegron $10
mirabegron
$10 per unit
- tamsulosin $9
tamsulosin
$9 per unit
- finasteride $3
finasteride
$3 per unit
- oxybutynin $2
oxybutynin
$2 per unit
- fesoterodine $1
fesoterodine
$1 per unit
What this shows sildenafil is the costliest in this class at $84.00/unit; generics in the same class run a fraction of that.
Generic availability vs other classes
89% of urinary medications have a generic available, ranking #4 of 22 therapeutic classes (the typical class sits near 74%).
Source: CMS NADAC generic-availability flags across all PlainMeds therapeutic classes. The dot is this class; the line is the cross-class median.
alfuzosin
Uroxatral
Alfuzosin is a medicine that helps men with enlarged prostate glands.
View details →
bethanechol
Urecholine
Bethanechol helps you to urinate if you have trouble emptying your bladder.
View details →
darifenacin
Enablex
Darifenacin (Enablex) is a medicine that helps control an overactive bladder.
View details →
dutasteride
Avodart
Dutasteride and tamsulosin hydrochloride capsules contain two medicines to treat enlarged prostate in men.
View details →
dutasteride/tamsulosin
Jalyn
This medicine combines two drugs to treat enlarged prostate in men.
View details →
fesoterodine
Toviaz
Fesoterodine is a medicine that helps control an overactive bladder.
View details →
finasteride
Proscar, Propecia
Finasteride is a medicine used to treat hair loss in men.
View details →
mirabegron
Myrbetriq
Mirabegron is a medicine that helps control an overactive bladder.
View details →
oxybutynin
Ditropan
Oxybutynin extended-release tablets help control an overactive bladder.
View details →
phenazopyridine OTC
Pyridium, AZO
Phenazopyridine is a medicine that can relieve urinary pain.
View details →
potassium citrate
Urocit-K
Potassium citrate is a medicine that helps manage kidney problems.
View details →
sildenafil
Viagra, Revatio
Sildenafil is a medicine used to treat erectile dysfunction (ED) in men.
View details →
solifenacin
Vesicare
Solifenacin (Vesicare) is a medicine that helps control an overactive bladder.
View details →
tadalafil
Cialis
Tadalafil (Cialis) is a medicine that helps men with erectile dysfunction (ED) or enlarged prostate (BPH).
View details →
tamsulosin
Flomax
Tamsulosin (Flomax) helps to improve urination in men with enlarged prostate glands.
View details →
tolterodine
Detrol
Tolterodine extended-release capsules help control an overactive bladder.
View details →
trospium
Sanctura
Trospium chloride (Sanctura) helps control an overactive bladder.
View details →
vibegron
Gems
Gemtesa is a medicine that helps control an overactive bladder.
View details →
Understanding the Urinary Category
The Urinary category currently lists 18 medications in this database, each drawn from FDA drug labels and grouped by therapeutic classification. Medications for overactive bladder, benign prostatic hyperplasia (BPH), urinary tract infections, and kidney stones. Clinical guidelines usually treat these medications as a reference set when weighing treatment options, switching strategies, or comparing safety profiles.
Within this category you'll find examples such as tadalafil, finasteride, sildenafil, alongside 15 other entries. Each drug page links to the same underlying FDA data, labeled uses, adverse events reported to FAERS, documented interactions, warnings, and, where available, NADAC acquisition pricing from CMS. Over-the-counter and prescription options can sit in the same category but follow different regulatory pathways: OTC products have simplified labeling aimed at self-care, while prescription drugs include detailed monographs meant for clinicians. That distinction matters when comparing dosing, monitoring requirements, and contraindications.
Browsing a category is a research starting point, not a treatment recommendation. Effectiveness, tolerability, and cost for any individual patient depend on the specific condition, comorbidities, other medications, genetics, and insurance coverage, none of which can be inferred from a category list alone. FAERS report counts, recall history, and shortage status all evolve as new data is reported to the FDA, so the relative standing of drugs in this class can shift month to month. This page is for educational purposes only and is not medical advice, a licensed clinician is the right source for personalized guidance.
Explore other categories
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled and last refreshed May 2026. See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.